# MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

> **NCT01380145** · PHASE1 · COMPLETED · sponsor: **Ludwig Institute for Cancer Research** · enrollment: 13 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **BIOLOGICAL:** recMAGE-A3 Protein + AS15 Adjuvant

## Key facts

- **NCT ID:** NCT01380145
- **Lead sponsor:** Ludwig Institute for Cancer Research
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2014-07
- **Final completion:** 2014-11
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2022-10-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01380145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01380145, "MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01380145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*